Search results
The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Zacks via Yahoo Singapore Finance· 12 hours agoThis will lower treatment costs and burden for patients. Kisunla will be the second drug on the...
This will lower treatment costs and burden for patients. Kisunla will be the second drug on the...